Delivery Order SPE2DB22D2206-SPE2DB25FEA14

Award Date 10/30/24
Potential Completion Date 10/31/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division. The $3,056.94 firm fixed-price delivery order is for the supply of XYLOCAINE-MPF 1% VIAL 5ML, a local anesthetic medication, with a completion date of June 13, 2024. This award is a task order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XYLOCAINE-MPF 1% VIAL 5ML, a local anesthetic medication. The contract is a Delivery Order with a Firm Fixed Price of $1,386.88 and an ultimate completion date of September 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply XYLOCAINE-MPF 2% 100 MG/5 ML 5ML pharmaceuticals. The $1,742.00 delivery order has a completion date of January 11, 2024. Amerisourcebergen Drug Corp, as a prime contractor, provides a range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities to support military treatment programs. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,491.66 firm fixed-price delivery order contract is for the supply of XYLOCAINE 1%-EPI 1:100,000 10ML, a local anesthetic medication. The contract has an ultimate completion date of March 7, 2024 and was awarded on March 6, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract, valued at $1,179.40, is for the delivery of pharmaceutical products, specifically XYLOCAINE-MPF 1%-EPI 1:200,000 30ML, to support various government agencies and healthcare programs. The contract is a firm fixed-price Delivery Order, with a period of performance running through September 2024. Amerisourcebergen, a major supplier of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,008.52 firm-fixed-price delivery order is for XYLOCAINE 2%-EPI 1:200,000 10ML, a specialty medication. The contract has an ultimate completion date of November 21, 2024 and was awarded on November 20, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,727.07, is for the delivery of XYLOCAINE 2%-EPI 1:200,000 20ML, a local anesthetic medication, with a completion date of January 5, 2024. This is a firm fixed-price delivery order contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $2,997.52, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award, with ID SPE2DB22D2006|SPE2DB25FV8JW, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,120.98 firm-fixed-price delivery order is for the supply of 4567268890 ! LIDOCAINE HCL 1% VIAL 10ML and has a completion date of February 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,458.36 delivery order is a firm fixed-price contract that provides a variety of pharmaceutical products and medical supplies, including specialty medications, generic drugs, vaccines, syringes, and other medical commodities. This award is a part of Amerisourcebergen's larger $999,999,999...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FEA14
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,790.11 firm fixed-price delivery order is for the supply of XYLOCAINE-MPF 2% 40 MG/2 ML VL 2ML, a pharmaceutical product, with a period of performance ending on October 31, 2024. The award is not designated as a set-aside contract.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order award is issued against that IDC. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 1/29/25, 9:24 AM